Ascentage Pharma Group International AAPG
NASDAQ AAPG
$15.10 -1.24 (-7.63%)
As of: Oct 22, 2026 · 10:39 AM EDT

Ascentage Pharma Group International (AAPG) Total Debt (2023)

Updated

Analysis

Ascentage Pharma Group International (AAPG) Total Debt (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,170.23 Bn 1,138.82 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 648.85 Bn 568.71 Bn 17.30 Bn 44.65 Bn
3 AbbVie 504.91 Bn 478.02 Bn 12.70 Bn 70.82 Bn
4 Merck 368.25 Bn 322.63 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 303.41 Bn 267.40 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 268.65 Bn 242.33 Bn 12.86 Bn 32.35 Bn
7 Amgen 242.96 Bn 198.36 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 195.01 Bn 169.21 Bn 6.22 Bn 26.25 Bn
9 Pfizer 173.22 Bn 119.87 Bn 10.94 Bn 63.19 Bn
10 Ascentage Pharma Group International 1.34 Bn 307.21 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 2.57 Mn
API Access

Ascentage Pharma Group International Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=AAPG&period=max&api_key=YOUR_API_KEY